For health plans delivered, issued for delivery, or renewed on or after January 1, 2021, clinical review criteria used to establish a prescription drug utilization management protocol must be evidence-based and updated on a regular basis through review of new evidence, research, and newly developed treatments.
[ 2019 c 171 § 2.]
NOTES:
Rules—2019 c 171: See note following RCW 48.43.420.